Skip to main content
. 2019 Mar;60(3):353–361. doi: 10.2967/jnumed.118.216069

FIGURE 3.

FIGURE 3.

Whole-body coronal PET/CT images acquired 3 h after 89Zr-DFO-ZEGFR:03115 administration spiked with different amounts of nonlabeled ZEGFR:03115 in mice bearing CAL27 tumors: 2 μg of 89Zr-DFO-ZEGFR:03115 injected (A); 1 μg of ZEGFR:03115 injected 30 min before injection of 2 μg of 89Zr-DFO-ZEGFR:03115 (B); 5 μg of ZEGFR:03115 injected 30 min before injection of 2 μg of 89Zr-DFO-ZEGFR:03115 (C); 10 μg of ZEGFR:03115 injected 30 min before injection of 2 μg of 89Zr-DFO-ZEGFR:03115 (D); 10 μg of ZEGFR:03115 coinjected with 2 μg of 89Zr-DFO-ZEGFR:03115 (E).